Abstract
The worldwide outbreak of the Coronavirus pandemic (COVID-19) and other emerging microbial infections has attracted particular interest for the design and development of new biocidal agents, with a broad spectrum of activity. Since then, efficient strategies need to be implemented for the rapid diagnosis, prevention, control and treatment of the SARS-CoV-2 virus and its variants. In the c…